- £1.02bn
- £1.31bn
- €3.07bn
2024 Interim Results
Brief: Uniphar Remains Focused On Reaching EUR 200 Mln EBITDA In Medium Term
Half Year Trading Update and Notice of Results
Holding(s) in Company
Director/PDMR Shareholding
Holding(s) in Company
Brief: Uniphar Says Performance In First Four Months In Line With Board's Expectations
AGM Statement
Holding(s) in Company
Director/PDMR Shareholding
Notice of AGM & Annual Report
Brief: Uniphar Says Well Positioned To Deliver FY Organic Gross Profit Growth Across All Divisions
Brief: Uniphar FY adjusted pretax profit EUR 53.321 million
2023 Preliminary Results
Holding(s) in Company
Brief: Uniphar Says Co Sees 2024 Organic Gross Profit Growth For Uniphar Pharma Up Double Digit
Directorate Change
Full Year Trading Update and Notice of Results
Holding(s) in Company